NHIA adds Fresenius Kabi to advisory council to address home infusion issues
By HME News Staff
Updated 9:41 AM CDT, Wed April 29, 2026
ALEXANDRIA, Va. – The National Home Infusion Association has announced that Fresenius Kabi has joined its Future of Infusion Advisory Council (FIAC), a strategic group comprising manufacturers and service companies that support home and alternative site infusion professionals. The group also works with the association’s staff and board of directors to address critical issues, challenges and opportunities. “Fresenius Kabi is committed to supporting patients who rely on infusion therapies, and joining NHIA’s Future of Infusion Advisory Council provides an important forum to advance this work,” said Pete Allen, senior vice president, IV Therapy and Nutrition, Fresenius Kabi USA. “We are focused on delivering high-quality parenteral nutrition and IV solutions and enhancing U.S. supply reliability through continued investment in manufacturing. We look forward to further advancing infusion care across the country.” Fresenius Kabi, a part of Fresenius, is a provider of essential medicines and medical technologies for infusion, transfusion and clinical nutrition. In the U.S., the company offers a broad portfolio of essential, high-quality medicines and operates an expanding network of state-of-the-art manufacturing facilities.
Comments